CA2112397A1 — Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
Assigned to Organon Pharma UK Ltd · Expires 1993-03-04 · 33y expired
What this patent protects
Compounds of formula (I), and salts and prodrugs thereof wherein n is 1, 2 or 3; X represents O or S; R1 represents optionally substituted phenyl; R2 represents aryl, heteroaryl, benzhydryl, or benzyl; R4 and R5 each independently represent H, halo, CH2OR9, C1-6alkyl, oxo, CO2R10…
USPTO Abstract
Compounds of formula (I), and salts and prodrugs thereof wherein n is 1, 2 or 3; X represents O or S; R1 represents optionally substituted phenyl; R2 represents aryl, heteroaryl, benzhydryl, or benzyl; R4 and R5 each independently represent H, halo, CH2OR9, C1-6alkyl, oxo, CO2R10 or CONR10R11; R8 represents H, COR9, CO2R10 or optionally substituted C1-6alkyl; R9 represents H, C1-6alkyl or phenyl; and R10 and R11 each independently represent H or C1-6alkyl; are tachykinin antagonists. They and compositions thereof are useful in medicine.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.